alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT      32**

**CERTIFICATIONS**

|                                |                                                                                                |                                               |
|-------------------------------------|-----------------------------------------------------------------------------------------------------|----------------------------------------------------|
| DATE:              December 8, 2006 | By:                                                                                       | /s/ Anna              E.              Gluskin |
|                                | Anna                E. Gluskin, Chief Executive Officer(Principal                Executive Officer) |
|                                      |                                                                                              |                                             |
|-------------------------------------------|---------------------------------------------------------------------------------------------------|--------------------------------------------------|
| DATE:              December 8, 2006  | By:                                                                                     | /s/ Rose              C.              Perri |
|                                      | Rose C. Perri, Chief Financial Officer(Principal Financial and Accounting                Officer) |

----
Exhibit 31.2
**CERTIFICATION**
     I, Ullrich E. Porzig, certify that:
 1. I have reviewed this Form 10-Q of Payless ShoeSource, Inc., aDelaware corporation;  2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect tothe period covered by this report;  3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in allmaterial respects the financial condition, results of operations andcash flows of the registrant as of, and for, the periods presented inthis report;  4. The registrant’s other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)for the registrant and have:
 (a) Designed such disclosure controls and procedures, orcaused such disclosure controls and procedures to be designedunder our supervision, to ensure that material informationrelating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities,particularly during the period in which this report is beingprepared;  (b) Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this reportbased on such evaluation and  (c) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and
 5. The registrant’s other certifying officer(s) and I havedisclosed, based on our most recent evaluation of internal controlover financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or personsperforming the equivalent functions):
 (a) All significant deficiencies and material weaknesses inthe design or operation of internal control over financialreporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and reportfinancial information; and  (b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in theregistrant’s internal control over financial reporting.
Date: June 7, 2004           /s/     Ullrich E. Porzig    Ullrich E. Porzig   Senior Vice President,Chief Financial Officer and Treasurer(Principal Financial and Accounting Officer)
**Exhibit 99.5**

 

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION1350, AS ADOPTED PURSUANTTO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report of Horizon Group Properties, Inc. (the “Company”) on Form 10-Qfor the period ending May 14, 2003 as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, David R. Tinkham, ChiefFinancial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, asadopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)      The Report fully complieswith the requirements of section 13(a) or 15(d) of the Securities Exchange Actof 1934; and

 

(2)      The information containedin the Report fairly presents, in all material respects, the financialcondition and result of operations of the Company.

 

 
| Dated: | May 15, 2003 |                     | /s/ David R.  Tinkham |   |
|--------|--------------|--------------------------|-----------------------|--------|
|   |         | David R.  Tinkham        |
|   |         | Chief  Financial Officer |

 

1

----
##### 



Exhibit 32.1
 CERTIFICATION OF CEO
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934, as amended; and
 (2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of Global as of the dates
and for periods presented as required by such Report.
 /s/ B. K. CHINB.K. ChinChief Executive OfficerFebruary 22, 2008
#### STATE of Missouri, Respondent, v. Larry Mark WALLER, Appellant.

No. WD 41739.

Missouri Court of Appeals, Western District.

Nov. 21, 1989.

Motion for Rehearing and/or Transfer to Supreme Court Denied Jan. 2, 1990.

Mark T. Kemp ton, Wesner Kempton and Russell, Sedalia, for appellant.

William L. Webster, Atty. Gen., Ronald L. Jurgeson, Asst. Atty. Gen., Jefferson City, for respondent.

Before BERREY, P.J., and TURNAGE and ULRICH, JJ.

*419ORDER

PER CURIAM.

Appeal from conviction for sale of methamphetamine, § 195.020, RSMo 1986, and sentence of imprisonment of five years.

Judgement affirmed. Rule 30.25(b).
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA

v.

TERRY JAMES WALLACE

PETITION OF: CHRIS A. PENTZ

:

:

:

:

:

:

:

:

:

:

No. 105 WM 2020

ORDER

PER CURIAM

AND NOW, this 23rd day of February, 2021, in consideration of the Application to 

Withdraw as Counsel filed by Chris Pentz, Esquire, and the request for appointment of 

new counsel advanced by Terry James Wallace (Wallace), this matter is REMANDED to 

the Court of Common Pleas of Clearfield County. 

It is noted that a court-appointed attorney’s representation continues on direct 

appeal through allocatur review. See Pa.R.Crim.P. 122, Note. Attorney Pentz, however, 

did not file a counseled Petition for Allowance of Appeal on behalf of Wallace. 

Furthermore, Attorney Pentz’s Application to Withdraw as Counsel fails to satisfy the 

general standard governing such requests. See Commonwealth v. Santiago, 978 A.2d 

349, 361 (Pa. 2009) (discussing the requirements for an attorney’s application to withdraw 

on direct appeal; instructing that counsel provide, inter alia, “a summary of the procedural 

history and facts, with citations to the record, [as well as] counsel's reasons for concluding 

that the appeal is frivolous”).
[105 WM 2020] - 2

The Court of Common Pleas of Clearfield County is ORDERED to determine 

whether to permit Attorney Pentz to withdraw and, if so, whether to grant Wallace’s 

request for appointment of new counsel. 

The Court of Common Pleas of Clearfield County is ORDERED to enter its order 

regarding this remand within 90 days and to notify this Court promptly of its determination.
[Federal Register Volume 60, Number 51 (Thursday, March 16, 1995)]
[Notices]
[Page 14307]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6533]



-----------------------------------------------------------------------


NATIONAL SCIENCE FOUNDATION

Advisory Panel for Physiology and Behavior; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation (NSF) announces the 
following meeting:

    Name: Advisory Panel for Physiology and Behavior (Ecological & 
Evolutionary Physiology).
    Date and time: April 5-7, 1995; 8:30 a.m.-5:00 p.m.
    Place: National Science Foundation, Room 320, 4201 Wilson Blvd., 
Arlington, VA
    Type of meeting: Part-Open.
    Contact person: Dr. David Vleck, Program Director, Ecological & 
Evolutionary Physiology, Division of Integrative Biology and 
Neuroscience, Suite 685, National Science Foundation, 4201 Wilson 
Boulevard, Arlington, VA 22230, Telephone: (703) 306-1421.
    Purpose of meeting: To provide advice and recommendations 
concerning proposals submitted to NSF for financial support.
    Minutes: May be obtained from the contact person listed above.
    Agenda: Open Session: April 7, 1995; 10:00 a.m. to 11:00 a.m.--
for a discussion, Integrative Biology and Neuroscience on research 
trends and opportunities assessment procedures in Ecological and 
Evolutionary Physiology.
    Closed Session: April 5th and 6th, 8:30 a.m.-5:00 p.m.; April 
7th, 8:30 a.m. to 10:00 a.m.; 11:00 a.m. to 5:00 p.m. To review and 
evaluate Ecological & Evolutionary Physiology proposals as part of 
the selection process for awards.
    Reason for closing: The proposals being reviewed include 
information of a proprietary or confidential nature, including 
technical information; financial data, such as salaries; and 
personal information concerning individuals associated with the 
proposals. These matters are exempt under 5 U.S.C. 552b(c), (4) and 
(6) of the Government in the Sunshine Act.

    Dated: March 13, 1995.
M. Rebecca Winkler,
Committee Management Officer.
[FR Doc. 95-6533 Filed 3-15-95; 8:45 am]
BILLING CODE 7555-01-M
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02-15-00431-CR

Derrick Cash Smith

v.

The State of Texas §

§

§

§

§ From County Criminal Court No. 2

of Denton County (C R-2014-06227-B)

June 30, 2016

Opinion by Justice Dauphinot

(nfp)



### JUDGMENT

This court has considered the record on appeal in this case and holds that

there was no error in the tria l court’s judgment. It is ordered that the judgment of

the trial court is affirmed.

SECOND DISTRICT COURT OF APPEALS

By _/s/ Lee Ann Daup hinot______

________ Justice Lee Ann Dauphinot
Third District Court of Appeal

State of Florida 

Opinion filed December 13, 2023.

Not final until disposition of timely filed motion for rehearing.

________________

No. 3D23-0786

Lower Tribunal No. F06-37066

________________

Lorenzo Torres,

Appellant,

vs.

The State of Florida,

Appellee.

An Appeal under Florida Rule of Appellate Procedure 9.315(a) from 

the Circuit Court for Miami-Dade County, Teresa Pooler, Judge.

Lorenzo Torres, in proper person.

Ashley Moody, Attorney General, and Magaly Rodriguez, Assistant 

Attorney General, for appellee.

Before FERNANDEZ, SCALES and MILLER, JJ. 

PER CURIAM.

Affirmed.
* This order and judgment is not binding precedent, except under the doctrines of

law of the case, res judicata, and collateral estoppel. This court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.

** After examining the briefs and the appellate record, this three-judge panel has determined unanimously that oral argument would not be of material assistance in the determination of this appeal. See Fed. R. App. P. 34(a); 10th Cir. R. 34.1.9. The cause is therefore ordered submitted without oral argument.

UNITED STATES COURT OF APPEALS Filed 6/26/96 TENTH CIRCUIT
LORENZO FUENTES JIMENEZ, Plaintiff - Appellant, vs. BILL R. STORY, Warden and unknown defendant, Defendant - Appellee. No. 95-1468 (D.C. No. 95-S-2368) (D. Colo)

ORDER AND JUDGMENT *
Before SEYMOUR, Chief Judge, KELLY, and LUCERO, Circuit Judges. **
Mr. Jimenez, an inmate appearing pro se, appeals from the dismissal of his civil rights complaint and action brought pursuant to 42 U.S.C. § 1983. Because his complaint seeks relief not limited to monetary compensation, and he has failed to comply with the administrative grievance procedure, see 28 C.F.R. § 542.10-.16 (1994), his claim is properly dismissed as he has failed to exhaust administrative remedies. See McCarthy v.- 2 -

Madigan , 503 U.S. 140, 144-45 (1992). We additionally note that Mr. Jiminez’s petition fails on the merits because the Sentencing Reform Act did not require a release as of October 31, 1992, as he contends. AFFIRMED. We GRANT Mr. Jimenez’s Motion for Leave to Proceed on Appeal Without Prepayment of Costs or Fees. The mandate shall issue forthwith.

Entered for the Court

Paul J. Kelly, Jr. Circuit Judge
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

March 15, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3974

Academy, Ltd:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
#### CATHERINE S. BLANTON, Administratrix of the Estate of C. G. BLANTON, Deceased, v. DOUBLE COLA BOTTLING COMPANY, INC., a Corporation.

(Filed 29 February, 1956.)

Appeal by plaintiff from *Pless, J.,*September Term, 1955, Ruther-eord.

Affirmed.

Civil action for wrongful death growing out of an automobile-truck collision.

Plaintiff’s intestate, her husband, was operating his automobile when it collided with a truck being operated by an employee of defendant company. Each party alleges that as the automobiles approached each other, going in opposite directions, the other failed to turn reasonably *632to the right of his side of the road, and a head-on collision resulted. Plaintiff’s intestate died as a result thereof. Issues of negligence and contributory negligence were submitted to the jury, and both were answered in the affirmative. From judgment on the verdict the plaintiff appealed.

*Ray S. Farris and James B. Ledford for plaintiff appellant.*

*J. Paul Head, J. Nat Hamrick, and Mullen, Holland & Cooke for defendant appellee.*

Per Cueiam.

The trial in the court below was fairly and impartially conducted in substantial accord with the decisions of this Court. Appropriate issues were submitted to the jury and answered by it adversely to plaintiff. The record fails to disclose any exception of sufficient merit to require discussion. Hence the judgment entered must be

Affirmed.
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

August 19, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-4405

David C. Poole Company:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 17, 2019

RE: Product Exclusion Request Number USTR-2018-0025-1889

Titan Flow Control: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/%2434_Billion_Exclusions_Gr

anted_September.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
EXHIBIT 99.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION
                     906 OF THE SARBANES-OXLEY ACT OF 2002


I, Murray Wilson, President and Chief Financial Officer of Ciro International,
Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, 18 U.S.C. Section 1350, that:

(1)   the Quarterly Report on Form 10-QSB of the Company for the quarter ended
March 31, 2001 (the "Report") fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C.
78m or 78o(d)); and

(2)   the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Date: June 11, 2003


/s/ Murray Wilson
-----------------
Murray Wilson
President and Chief Financial Officer



<PAGE>
Exhibit 32.2

SECTION 1350 CERTIFICATIONS

In connection with the Quarterly Report of Killbuck Bancshares, Inc. (the Company) on Form 10-Q for the period ending June 30, 2010 as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, Lawrence Cardinal, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as enacted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:



|1. | The Report fully complies with the requirements of section 13(a) or 15 (d) of the Securities Exchange Act of 1934,; and
|-- | -----------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |                      
|----------------------- |  | ---------------------
|By:                     |  | /s/ Lawrence Cardinal
|                       
|Lawrence Cardinal      
|Chief Financial Officer
|August 11, 2010        

A signed original of this
written statement required by Section 906 has been provided to Killbuck Bancshares, Inc. and will be retained by Killbuck Bancshares, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 10.4


Patent Assignment Agreement


(English Translation)







Party A Harbin Tianmu Pharmaceuticals Company Limited


Party B Harbin Lanhai Biochemical Company Limited








	
1.

	
Medicine name: Lanhai Spirulina Calcium Tablet








	
2.

	
Agreement period: November 1,2008- October 30, 2013








	
3.

	
Patent approval no:2007100725947; application date: August 20, 2007; approval date: March 14,2008








	
4.

	
Rights and obligation








	
  

	
1)

	
Party A shall have manufacture rights for this product and shall have all the rights for the patent.








	
  

	
2)

	
Party B shall shall provide all the formula and technology related to “Lanhai Spirulina Calcium Tablet”








	
  

	
3)

	
Party B shall provide all the necessary approval documents from the government.








	
  

	
4)

	
Party A shall in charge of manufacturing and sales for this product and comply on all the manufacture requirement.








	
  

	
5)

	
Party B shall continue to provide technical support for this product













	
5.

	
Main ingredients: Spirulina, oyster,sealwort,arillus longan, medlar, Chinese yam








	
6.

	
Total amount: $1,200,000








	
7.

	
Terms of Payment: Party A shall pay $1,200,000 in full by October 31, 2008








	
8.

	
Arbitration: All disputes in connection with this agreement thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case will be sent to the Party A’s district court.








	
9.

	
This agreement is made out in two originals, one for each party. Both of them have the same force and effect. This agreement will be effective after the general managers of both parties sign.












Party A Harbin Tianmu Pharmaceuticals Company Limited


General Manager: Mingli Yao







Party B Harbin Lanhai Biochemical Company Limited


General Manager: Shaobin Yu